XML 35 R24.htm IDEA: XBRL DOCUMENT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

3 Months Ended

Mar. 31, 2023

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Net Income (loss) Per Share

		For the Three Months Ended March 31, (Unaudited)
		2023				2022
Net income (loss) attributable to common shareholders		$	(1,187,487	)		$	(659,484	)
Weighted average number of shares of common stock outstanding:
Basic			19,806,622				19,718,330
Diluted			19,806,622				19,718,330
Net income (loss) attributable to common shareholders per share:
Basic		$	(0.06	)		$	(0.03	)
Diluted		$	(0.06	)		$	(0.03	)

Schedule of Reconciliation of shares

		For the Three Months Ended March 31, (Unaudited)
		2023				2022
Numerator:
Net Income (Loss)		$	(1,187,487	)		$	(659,484	)
Denominator:
Basic weighted-average shares			19,806,622				19,718,330
Effect of dilutive securities
Warrants			-				-
Options			-				-
Preferred Stock			-				-
Diluted Weighted Average Shares			19,806,622				19,718,330
Net Income (Loss) Per Common Share:
Basic		$	(0.06	)		$	(0.03	)
Diluted		$	(0.06	)		$	(0.03	)

Note: Warrants, options and preferred stock for the three months ended March 31, 2023 and 2022 are not included in the computation of diluted weighted average shares as such inclusion would be anti-dilutive.

Disaggregation Of Revenue

		For the three months ended March 31, (Unaudited)
		2023				2022
SteraMist Product		$	1,276,000			$	1,886,000
Service and Training			306,000				423,000
Total		$	1,582,000			$	2,309,000

Revenue by Geographic Region

		For the three months ended March 31, (Unaudited)
		2023				2022
United States		$	1,128,000			$	1,879,000
International			454,000				430,000
Total		$	1,582,000			$	2,309,000